Comparison of SARS-CoV-2 Evolution in Paediatric Primary Airway Epithelial Cell Cultures Compared with Vero-Derived Cell Lines. (2022)

First Author: Bamford CGG
Attributed to:  Repurposing FDA-Approved Drugs for Treatment of 2019-nCoV-induced Disease funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/v14020325

PubMed Identifier: 35215919

Publication URI: http://europepmc.org/abstract/MED/35215919

Type: Journal Article/Review

Volume: 14

Parent Publication: Viruses

Issue: 2

ISSN: 1999-4915